| International Journal of Molecular Sciences | |
| Long Non-Coding RNAs in Cancer and Development: Where Do We Go from Here? | |
| Monika Haemmerle2  Tony Gutschner1  | |
| [1] Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA;Department of Gynecologic Oncology and Reproductive Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; E-Mail: | |
| 关键词: functional genomics; genetically engineered mouse models (GEMM); long intergenic RNA (lincRNA); metastasis; metastasis-associated lung adenocarcinoma transcript 1 (MALAT1); HOX transcript antisense RNA (HOTAIR); | |
| DOI : 10.3390/ijms16011395 | |
| 来源: mdpi | |
PDF
|
|
【 摘 要 】
Recent genome-wide expression profiling studies have uncovered a huge amount of novel, long non-protein-coding RNA transcripts (lncRNA). In general, these transcripts possess a low, but tissue-specific expression, and their nucleotide sequences are often poorly conserved. However, several studies showed that lncRNAs can have important roles for normal tissue development and regulate cellular pluripotency as well as differentiation. Moreover, lncRNAs are implicated in the control of multiple molecular pathways leading to gene expression changes and thus, ultimately modulate cell proliferation, migration and apoptosis. Consequently, deregulation of lncRNA expression contributes to carcinogenesis and is associated with human diseases, e.g., neurodegenerative disorders like Alzheimer’s Disease. Here, we will focus on some major challenges of lncRNA research, especially loss-of-function studies. We will delineate strategies for lncRNA gene targeting
【 授权许可】
CC BY
© 2015 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202003190017467ZK.pdf | 1384KB |
PDF